NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (31)
2024
2023
-
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study
Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 2105-2114
2022
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
2020
-
Serodiscordant patients with systemic sclerosis: When antibody does not correspond to skin involvement
Clinical and Experimental Rheumatology, Vol. 38, pp. S106-S114
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
-
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome
Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49
2017
-
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study
Autoimmunity Reviews, Vol. 16, Núm. 3, pp. 253-257
-
Enfermedades autoinflamatorias en el adulto. Características clínicas e implicaciones pronósticas
Revista Clinica Espanola
-
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group
Clinical Reviews in Allergy and Immunology, Vol. 52, Núm. 1, pp. 71-80
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
-
Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome
Clinical Rheumatology, Vol. 35, Núm. 3, pp. 825-828
2015
-
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study
Medicine (United States), Vol. 94, Núm. 32
2014
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745